# DESCRIPTION

## BACKGROUND

- limitations of cisplatin

## SUMMARY

- application of Lipoplatin

## DETAILED DESCRIPTION

- provide various embodiments of the present compositions and methods

### DEFINITIONS

- define singular and plural forms
- define "comprising"
- define "consisting essentially of"
- define "consisting of"
- explain ranges and subranges
- explain numerical designations and approximations
- define "effective amount"
- define "treating" or "treatment"
- define "surgery" or "surgical resection"
- define "tumor recurrence"
- define "time to tumor recurrence"
- define "disease free survival"
- define "overall survival"
- define "progressive disease"
- define "relative risk"
- define "monotherapy"
- define "stage I-IV cancer"
- define "triple negative breast cancer"

### Descriptive Embodiments

- introduce Lipoplatin monotherapy
- describe first dose administration
- describe second dose administration
- outline therapy cycle repetition
- specify effective dose determination
- provide non-limiting examples of first and second doses
- list cancers treatable by the method
- describe therapy lines (first, second, third)
- specify previous treatments (surgical resection, radiotherapy, oxaliplatin therapy)
- outline routes of administration
- describe maintenance therapy
- introduce second chemotherapeutic agent administration
- describe DNA alkylating agents
- describe platinum-based compounds
- describe topoisomerase inhibitors
- describe dual topoisomerase I and II inhibitors
- describe antimetabolite agents
- list chemotherapeutic agents
- define FOLFOX and FOLFOX/BV
- describe therapeutic antibodies
- define Bevacizumab and biological equivalents
- define chemical and biological equivalents
- summarize study on Lipoplatin toxicity and effectiveness
- describe Lipoplatin composition and formulation
- outline method of administering Lipoplatin
- describe treatment cycles and dosages
- list types of cancer treatable with Lipoplatin
- describe routes of administration
- compare Lipoplatin with other therapies
- outline method of inhibiting tumor growth with Lipoplatin
- describe maintenance therapy with Lipoplatin
- outline method of treating cancer with Lipoplatin and radiation
- describe treatment of locally advanced Triple-negative Breast Cancer
- outline method of treating NSCLC with Lipoplatin and paclitaxel
- describe treatment of pancreatic cancer with Lipoplatin and gemcitabine
- outline method of treating mesothelioma with Lipoplatin
- describe pharmaceutical composition and kit

## EXPERIMENTAL

### Experiment No. 1

- describe Lipoplatin composition and method of making
- outline Lipoplatin method of administration
- define eligibility criteria for patients
- describe treatment plan
- outline patient evaluation
- define response criteria
- describe statistical analysis
- present patient characteristics
- report compliance with treatment
- present response rate and survival
- report toxicity
- discuss study results and implications

### Experiment No. 2

- introduce experiment design
- describe chemicals used
- describe cell line and culture conditions
- outline animal experiments
- describe F98 glial cells implantation in Fischer rat brain
- outline routes of drug administration
- describe platinum uptake in tumor and brain tissue
- outline Gamma Knife irradiation of brain tumor
- describe evaluation of mean survival time
- outline statistical analysis
- describe drugs accumulation in nucleus and cytoplasm of tumor cells
- describe drugs accumulation in tumor and contra lateral brain
- outline anti-cancer effect and toxicity of platinum compounds
- describe concomitant treatment with radiation
- summarize results of IA injection combined with tumor irradiation
- discuss temporary opening of the BBB
- conclude with general statements about the disclosure

